Successful treatment of infected residual pleural space after pulmonary resection with autologous platelet-leukocyte gel.
Complications of the residual pleural space after pulmonary resection have been reported to be between 5% and 40% depending on the type of resection, and they increase morbidity, mortality, hospital stays, and costs. The therapeutic use of autologous prepared platelet leukocyte-enriched gel is a relatively new technology for the stimulation and acceleration of soft tissue and bone healing. This gel can be applied to a diversity of tissue. We describe the case of a successful application through a chest tube of platelet leukocyte gel to treat an infected residual pleural space that developed after pulmonary lobectomy for lung cancer.
De Giacomo
Tiziano
T
Department of Thoracic Surgery, University of Roma Sapienza, Rome, Italy. tiziano.degiacomo@tin.it
Diso
Daniele
D
Ferrazza
Giancarlo
G
Venuta
Federico
F
Francioni
Federico
F
Coloni
Giorgio F
GF
D000368:Aged; D002177:Candidiasis / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000601:surgery; D005782:Gels; D006801:Humans; D017708:Leukocyte Transfusion; D008175:Lung Neoplasms / Q000601:surgery; D008297:Male; D017713:Platelet Transfusion; D010995:Pleural Diseases / Q000628:therapy*; D011013:Pneumonectomy; D011183:Postoperative Complications / Q000628:therapy*; D012074:Remission Induction; D013203:Staphylococcal Infections / Q000628:therapy*
D005782:Gels